AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35576498 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive AAC intervention
Number of subjects: 4
Study 35576498 — intervention group
Group type: EXPERIMENTAL
Intervention: Blended intervention (combination of ReST and AAC)
Number of subjects: 4
Study 33625063 — intervention group
Group type: EXPERIMENTAL
Intervention: VIBESR (deep learning-based superresolution reconstruction)
Number of subjects: 46
Study 33625063 — intervention group
Group type: EXPERIMENTAL
Intervention: VIBESR
Number of subjects: 46
Study 33625063 — intervention group
Group type: COMPARATOR
Intervention: VIBESD (standard VIBE images)
Number of subjects: 46
Study 32651146 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced‐osmolarity ORS and propranolol (n = 34)
Number of subjects: 70
Study 32651146 — intervention group
Group type: COMPARATOR
Intervention: No medication (Control group, n = 36)
Number of subjects: 70
Study 36316831 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral reflective training programme (CBRT-P)
Number of subjects: 163
Study 36316831 — intervention group
Group type: COMPARATOR
Intervention: Comparison group
Number of subjects: 163
Study 32349074 — intervention group
Group type: EXPERIMENTAL
Intervention: Calibrated esophageal pressure measurements during pneumoperitoneum-Trendelenburg and PEEP administration
Number of subjects: 30
Study 32349074 — intervention group
Group type: COMPARATOR
Intervention: Uncalibrated esophageal pressure measurements
Number of subjects: 30
Study 33727997 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided pudendal nerve block combined with deep sedation using propofol (Group PNB)
Number of subjects: 120
Study 33727997 — intervention group
Group type: COMPARATOR
Intervention: Spinal anesthesia (Group SA)
Number of subjects: 120
Study 32932396 — intervention group
Group type: EXPERIMENTAL
Intervention: Addipak (n = 12)
Number of subjects: 27
Study 32932396 — intervention group
Group type: EXPERIMENTAL
Intervention: PuriLens Plus (n = 15)
Number of subjects: 27
Study 32932396 — intervention group
Group type: COMPARATOR
Intervention: Buffered and nonbuffered saline solutions
Number of subjects: 27
Study 36156472 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholecalciferol 5000 IU/day for 12 weeks
Number of subjects: 60
Study 36156472 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 34339851 — intervention group
Group type: EXPERIMENTAL
Intervention: LBBAP-optimized CRT (LOT-CRT)
Number of subjects: 112
Study 34339851 — intervention group
Group type: COMPARATOR
Intervention: Biventricular pacing (BiV-CRT)
Number of subjects: 112
Study 34339851 — intervention group
Group type: COMPARATOR
Intervention: LBBAP
Number of subjects: 112
Study 35731881 — intervention group
Group type: EXPERIMENTAL
Intervention: Conversations about their perfect day
Number of subjects: 2
Study 35731881 — intervention group
Group type: COMPARATOR
Intervention: Conversations focusing on disagreement (e.g., why each supports their own party)
Number of subjects: 2
Study 35731881 — intervention group
Group type: COMPARATOR
Intervention: Conversations (both studies)
Number of subjects: 2
Study 32077140 — intervention group
Group type: EXPERIMENTAL
Intervention: Meclizine
Number of subjects: 12
Study 32077140 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 616586506 — intervention group
Group type: EXPERIMENTAL
Intervention: Normative message indicating participant is in the lowest 20th percentile of intake
Number of subjects: 167
Study 616586506 — intervention group
Group type: COMPARATOR
Intervention: Control group (no FV message)
Number of subjects: 167
Study 616586506 — intervention group
Group type: EXPERIMENTAL
Intervention: Recommendation group (4-5 cups per day)
Number of subjects: 167
Study 616586506 — intervention group
Group type: EXPERIMENTAL
Intervention: Normative group (80% of students ate more)
Number of subjects: 167
Study 616586506 — intervention group
Group type: EXPERIMENTAL
Intervention: Normative group (80% of students ate less)
Number of subjects: 167
Study 615918851 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone intravitreal implant (Ozurdex)
Number of subjects: 40
Study 35319976 — intervention group
Group type: EXPERIMENTAL
Intervention: Empathic-mindset intervention (45-70 min online exercise)
Number of subjects: 5822
Study 35319976 — intervention group
Group type: COMPARATOR
Intervention: Active placebo control
Number of subjects: 5822
Study 33577373 — intervention group
Group type: EXPERIMENTAL
Intervention: Ziv-aflibercept
Number of subjects: 56
Study 33577373 — intervention group
Group type: COMPARATOR
Intervention: Control (existing anti-VEGF regimen)
Number of subjects: 56
Study 32845114 — intervention group
Group type: EXPERIMENTAL
Intervention: Roflumilast cream 0.5%
Number of subjects: 89
Study 32845114 — intervention group
Group type: EXPERIMENTAL
Intervention: Roflumilast cream 0.15%
Number of subjects: 89
Study 32845114 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 89
Study 34645147 — intervention group
Group type: COMPARATOR
Intervention: Intensive insulin therapy alone
Number of subjects: 32
Study 34645147 — intervention group
Group type: COMPARATOR
Intervention: Intensive insulin therapy + glutamine
Number of subjects: 32
Study 34645147 — intervention group
Group type: COMPARATOR
Intervention: Conventional insulin therapy + glutamine
Number of subjects: 32
Study 35130547 — intervention group
Group type: EXPERIMENTAL
Intervention: IQP-LU-104 high dose (104HD)
Number of subjects: 108
Study 35130547 — intervention group
Group type: EXPERIMENTAL
Intervention: IQP-LU-104 low dose (104LD)
Number of subjects: 108
Study 35130547 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 108
Study 34029168 — intervention group
Group type: EXPERIMENTAL
Intervention: Highly interactive consent form
Number of subjects: 576
Study 34029168 — intervention group
Group type: COMPARATOR
Intervention: Other consent form variations
Number of subjects: 576
Study 32732353 — intervention group
Group type: EXPERIMENTAL
Intervention: Denosumab 60 mg every 6 months (Q6M)
Number of subjects: 909
Study 32732353 — intervention group
Group type: EXPERIMENTAL
Intervention: Denosumab 60 mg every 3 months (Q3M)
Number of subjects: 909
Study 32732353 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 909
Study 32732353 — intervention group
Group type: EXPERIMENTAL
Intervention: Denosumab (all dose groups)
Number of subjects: 909
Study 35731737 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium supplementation (0, 0.5, 1, 2.5, 5, and 10 mM)
Number of subjects: 0
Study 35731737 — intervention group
Group type: COMPARATOR
Intervention: Cadmium (150 μM)
Number of subjects: 0
Study 33789616 — intervention group
Group type: EXPERIMENTAL
Intervention: rHSA/G‐CSF 1500 μg
Number of subjects: 320
Study 33789616 — intervention group
Group type: COMPARATOR
Intervention: rhG‐CSF 5 μg/kg
Number of subjects: 320
Study 33789616 — intervention group
Group type: EXPERIMENTAL
Intervention: rHSA/G‐CSF 2400 μg
Number of subjects: 320
Study 33789616 — intervention group
Group type: EXPERIMENTAL
Intervention: rHSA/G‐CSF 1800 μg to 2400 μg
Number of subjects: 320
Study 32624429 — intervention group
Group type: EXPERIMENTAL
Intervention: Formal education (instructional video on proper TEA technique)
Number of subjects: 76
Study 32624429 — intervention group
Group type: COMPARATOR
Intervention: Traditional bedside training by attending physicians
Number of subjects: 76
Study 32624429 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (formal education and traditional training)
Number of subjects: 76
Study 32624429 — intervention group
Group type: EXPERIMENTAL
Intervention: More experienced residents (having placed more epidural catheters)
Number of subjects: 76
Study 34535402 — intervention group
Group type: EXPERIMENTAL
Intervention: LIFT (lower-body resistance exercise priming; trap bar deadlifts, 6 × 4 repetitions up to 85% of one repetition maximum)
Number of subjects: 16
Study 34535402 — intervention group
Group type: EXPERIMENTAL
Intervention: RUN (cricket-specific running priming; 6 × 35.36 m sprints including a 180° change of direction)
Number of subjects: 16
Study 34535402 — intervention group
Group type: COMPARATOR
Intervention: CON (passive rest)
Number of subjects: 16
Study 32165399 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg of MS-Contin (morphine)
Number of subjects: 21
Study 34242911 — intervention group
Group type: EXPERIMENTAL
Intervention: WFM (Tiger Tech Warfighter Monitor)
Number of subjects: 26
Study 34242911 — intervention group
Group type: COMPARATOR
Intervention: Chest ECG (2-lead)
Number of subjects: 26
Study 35385827 — intervention group
Group type: EXPERIMENTAL
Intervention: Vi polysaccharide (ViPS) vaccine
Number of subjects: 62756
Study 35385827 — intervention group
Group type: EXPERIMENTAL
Intervention: Better household WASH
Number of subjects: 62756
Study 35385827 — intervention group
Group type: COMPARATOR
Intervention: Better household WASH in Hep A clusters
Number of subjects: 62756
Study 35385827 — intervention group
Group type: COMPARATOR
Intervention: Better household WASH in ViPS clusters
Number of subjects: 62756
Study 35385827 — intervention group
Group type: COMPARATOR
Intervention: Better household WASH in the population during the 2 years preceding the trial
Number of subjects: 62756
Study 33317658 — intervention group
Group type: EXPERIMENTAL
Intervention: Coloured versions of the Health Star Rating label
Number of subjects: 7545
Study 33317658 — intervention group
Group type: EXPERIMENTAL
Intervention: Health Star Rating label with just a summary indicator
Number of subjects: 7545
Study 33317658 — intervention group
Group type: COMPARATOR
Intervention: Monochrome labels providing nutrient-specific information
Number of subjects: 7545
Study 36083811 — intervention group
Group type: EXPERIMENTAL
Intervention: Complex of functional spatially oriented rehabilitation (including exercises with instructor, mechanotherapeutic technique with cyclic simulators, massage of paretic limbs)
Number of subjects: 44
Study 36083811 — intervention group
Group type: COMPARATOR
Intervention: Basic standard of rehabilitation alone (control group)
Number of subjects: 44
Study 34549356 — intervention group
Group type: EXPERIMENTAL
Intervention: Succinylated gelatin (4%) (GEL)
Number of subjects: 40
Study 34549356 — intervention group
Group type: COMPARATOR
Intervention: Compound sodium lactate (CSL)
Number of subjects: 40
Study 35812820 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus GG (LGG; ATCC 53103)
Number of subjects: 0
Study 35812820 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 35077606 — intervention group
Group type: EXPERIMENTAL
Intervention: MZ-004 900 μg
Number of subjects: 76
Study 35077606 — intervention group
Group type: EXPERIMENTAL
Intervention: MZ-004 1200 μg
Number of subjects: 76
Study 35077606 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study 35077606 — intervention group
Group type: EXPERIMENTAL
Intervention: MZ-004 (both doses)
Number of subjects: 76
Study 33278280 — intervention group
Group type: EXPERIMENTAL
Intervention: Early pregnancy loss treatment
Number of subjects: 275
Study 33278280 — intervention group
Group type: EXPERIMENTAL
Intervention: Black participants
Number of subjects: 275
Study 33278280 — intervention group
Group type: COMPARATOR
Intervention: Non-Black participants
Number of subjects: 275
Study 33278280 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjusted odds for Black participants
Number of subjects: 275
Study 32482490 — intervention group
Group type: EXPERIMENTAL
Intervention: CVT-301 (levodopa inhalation powder) 84 mg (+25 mg of oral carbidopa)
Number of subjects: 23
Study 32482490 — intervention group
Group type: COMPARATOR
Intervention: Oral carbidopa/levodopa (25/100 mg)
Number of subjects: 23
Study 32482490 — intervention group
Group type: EXPERIMENTAL
Intervention: CVT-301
Number of subjects: 23
Study 33836658 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine coinfusion (1 mg/kg bolus followed by 2 mg/kg/h infusion)
Number of subjects: 106
Study 33836658 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (equivalent volume bolus and infusion)
Number of subjects: 106
Study 33393600 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% lidocaine with 1:200,000 epinephrine
Number of subjects: 78
Study 33393600 — intervention group
Group type: EXPERIMENTAL
Intervention: Twin mix (2% lidocaine with 1:200,000 epinephrine and 1 mL of 4 mg dexamethasone)
Number of subjects: 78
Study 33370786 — intervention group
Group type: EXPERIMENTAL
Intervention: Wii-based program (n = 6)
Number of subjects: 12
Study 33370786 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 6)
Number of subjects: 12
Study 32546431 — intervention group
Group type: EXPERIMENTAL
Intervention: Tezacaftor/ivacaftor
Number of subjects: 300
Study 32546431 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 300
Study 36057658 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined complex decongestive therapy (CDT) with therapeutic ultrasound
Number of subjects: 39
Study 36057658 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined complex decongestive therapy (CDT) with faradic current
Number of subjects: 39
Study 36057658 — intervention group
Group type: COMPARATOR
Intervention: Complex decongestive therapy (CDT) alone (Control)
Number of subjects: 39
Study 34078453 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioral intervention (6-week online training)
Number of subjects: 0
Study 34078453 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based intervention (6-week online training)
Number of subjects: 0
Study 34078453 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 0
Study 34289784 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcipotriol 0.005% cream
Number of subjects: 80
Study 34289784 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacrolimus 0.03% ointment
Number of subjects: 80
Study 34289784 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical corticosteroid; Clobetasone butyrate 0.05% cream
Number of subjects: 80
Study 34289784 — intervention group
Group type: COMPARATOR
Intervention: Petrolatum (Placebo)
Number of subjects: 80
Study 34561667 — intervention group
Group type: EXPERIMENTAL
Intervention: Social stories
Number of subjects: 16
Study 34561667 — intervention group
Group type: COMPARATOR
Intervention: Standard leaflets
Number of subjects: 16
Study 34385669 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized melanoma genomic risk information (saliva sample for genetic testing, personalized melanoma risk booklet, telephone-based genetic counseling, educational booklet)
Number of subjects: 1025
Study 34385669 — intervention group
Group type: COMPARATOR
Intervention: Educational booklet (control group)
Number of subjects: 1025
Study 34385669 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized melanoma genomic risk information
Number of subjects: 1025
Study 36412685 — intervention group
Group type: EXPERIMENTAL
Intervention: [18F]fluciclovine PET/CT
Number of subjects: 138
Study 36412685 — intervention group
Group type: COMPARATOR
Intervention: [18F]fluorocholine PET/CT
Number of subjects: 138
Study 36412685 — intervention group
Group type: EXPERIMENTAL
Intervention: [18F]fluciclovine PET/CT (per-region analysis)
Number of subjects: 138
Study 36412685 — intervention group
Group type: COMPARATOR
Intervention: [18F]fluorocholine PET/CT (per-region analysis)
Number of subjects: 138
Study 34244055 — intervention group
Group type: EXPERIMENTAL
Intervention: Rifampicin resistance isolates with mutations in rpoB gene
Number of subjects: 702
Study 36176149 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-Assisted Therapy protocol with gesture training
Number of subjects: 0
Study 36176149 — intervention group
Group type: EXPERIMENTAL
Intervention: Expanded interaction possibilities to total body movements
Number of subjects: 0
Study 34366306 — intervention group
Group type: EXPERIMENTAL
Intervention: SMART: SmPh app-driven break reminders (visual exercise prompts) plus pedometer-based step intervention
Number of subjects: 159
Study 34366306 — intervention group
Group type: EXPERIMENTAL
Intervention: TRADE: worksite PA education with a manual plus American College of Sports Medicine guided PA prescription
Number of subjects: 159
Study 34366306 — intervention group
Group type: COMPARATOR
Intervention: CONTROL: usual work group
Number of subjects: 159
Study 35580661 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic step-up approach
Number of subjects: 83
Study 35580661 — intervention group
Group type: COMPARATOR
Intervention: Surgical step-up approach
Number of subjects: 83
Study 34570799 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-collected specimens
Number of subjects: 2458
Study 34570799 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-collected pharyngeal specimens
Number of subjects: 2458
Study 34570799 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-collected rectal specimens
Number of subjects: 2458
Study 33361868 — intervention group
Group type: EXPERIMENTAL
Intervention: Artificial Intelligence method for estimating fetal weights
Number of subjects: 0
Study 33361868 — intervention group
Group type: EXPERIMENTAL
Intervention: Another AI method created with all of the JSUM data
Number of subjects: 0
Study 33361868 — intervention group
Group type: COMPARATOR
Intervention: Published formulae for estimating fetal weights
Number of subjects: 0
Study 35477086 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress Management
Number of subjects: 0
Study 35477086 — intervention group
Group type: COMPARATOR
Intervention: Not available
Number of subjects: 0
Study 32652243 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 tablets of 5‐mg oxycodone
Number of subjects: 120
Study 32652243 — intervention group
Group type: COMPARATOR
Intervention: 10 tablets of 5‐mg oxycodone
Number of subjects: 120
Study 36028870 — intervention group
Group type: EXPERIMENTAL
Intervention: propofol‐remifentanil‐rocuronium‐sugammadex (group S)
Number of subjects: 84
Study 36028870 — intervention group
Group type: COMPARATOR
Intervention: cisatricurium and neostigmine (group C)
Number of subjects: 84
Study 32613345 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic partial mesorectal excision (R‐PME)
Number of subjects: 131
Study 32613345 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic partial mesorectal excision (L‐PME)
Number of subjects: 131
Study 34003370 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine clinical rehabilitation program + normoxic endurance training
Number of subjects: 39
Study 34003370 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine clinical rehabilitation program + hypoxic endurance training
Number of subjects: 39
Study 34003370 — intervention group
Group type: COMPARATOR
Intervention: Routine clinical rehabilitation program
Number of subjects: 39
Study 32488245 — intervention group
Group type: EXPERIMENTAL
Intervention: Khorasan wheat products
Number of subjects: 20
Study 32488245 — intervention group
Group type: COMPARATOR
Intervention: Control products made from organic semi‐whole‐grain modern wheat
Number of subjects: 20
Study 35969632 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo ELLIPTA dry-powder inhaler (DPI)
Number of subjects: 1232
Study 33463746 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem
Number of subjects: 0
Study 33463746 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximum likelihood estimation and ordinary-least-square-based two-stage estimation methods
Number of subjects: 0
Study 33119010 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic yogurt
Number of subjects: 90
Study 33119010 — intervention group
Group type: COMPARATOR
Intervention: Ordinary yogurt (Control)
Number of subjects: 90
Study 32847466 — intervention group
Group type: EXPERIMENTAL
Intervention: Urban online group (telerehabilitation)
Number of subjects: 52
Study 32847466 — intervention group
Group type: EXPERIMENTAL
Intervention: Regional online group (telerehabilitation)
Number of subjects: 52
Study 32847466 — intervention group
Group type: COMPARATOR
Intervention: Urban in-person group (control)
Number of subjects: 52
Study 33483125 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotions 101 course (n = 120)
Number of subjects: 243
Study 33483125 — intervention group
Group type: COMPARATOR
Intervention: Wait-list condition (n = 123)
Number of subjects: 243
Study 34134864 — intervention group
Group type: EXPERIMENTAL
Intervention: Video education
Number of subjects: 67
Study 34134864 — intervention group
Group type: COMPARATOR
Intervention: Written pamphlet education
Number of subjects: 67
Study 33229690 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual marking (Group 1)
Number of subjects: 50
Study 33229690 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital marking (Group 2)
Number of subjects: 50
Study 35964449 — intervention group
Group type: EXPERIMENTAL
Intervention: Psilocybin (Schedule I)
Number of subjects: 181
Study 35964449 — intervention group
Group type: EXPERIMENTAL
Intervention: Methamphetamine (Schedule II)
Number of subjects: 181
Study 35964449 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine (Schedule III)
Number of subjects: 181
Study 35964449 — intervention group
Group type: EXPERIMENTAL
Intervention: Alprazolam (Schedule IV)
Number of subjects: 181
Study 35964449 — intervention group
Group type: COMPARATOR
Intervention: Alcohol
Number of subjects: 181
Study 34606313 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-time continuous glucose monitoring
Number of subjects: 0
Study 34606313 — intervention group
Group type: COMPARATOR
Intervention: Intermittently scanned continuous glucose monitoring
Number of subjects: 0
Study 35275166 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent safety intervention including education on fall prevention, home medication review, home safety assessment, and occupational therapy home visits.
Number of subjects: 1396
Study 35275166 — intervention group
Group type: COMPARATOR
Intervention: Control group from the Systematic Assessment and Targeted Improvement of Services Following Yearly Surgical Outcomes Surveys.
Number of subjects: 1396
Study 35275166 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent safety intervention
Number of subjects: 1396
Study 34460132 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin plus standard care
Number of subjects: 96
Study 34460132 — intervention group
Group type: COMPARATOR
Intervention: Standard care alone
Number of subjects: 96
Study 34808519 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tDCS (2 mA for 20 min)
Number of subjects: 24
Study 34808519 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 24
Study 36319968 — intervention group
Group type: EXPERIMENTAL
Intervention: CNN model with clinical features
Number of subjects: 720
Study 36319968 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiomics Rad-score
Number of subjects: 720
Study 36319968 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep learning signatures
Number of subjects: 720